相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Cancer Statistics, 2021
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
MAP17 contributes to non-small cell lung cancer progression via suppressing miR-27a-3p expression and p38 signaling pathway
Qian Liang et al.
CANCER BIOLOGY & THERAPY (2021)
LncRNA PCAT7 promotes the malignant progression of breast cancer by regulating ErbB/PI3K/Akt pathway
Jiaoqun Zhou et al.
FUTURE ONCOLOGY (2021)
Lysophosphatidic acid (LPA) receptor modulators: Structural features and recent development
Bhagyalalitha Meduri et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)
A novel mechanism underlying alcohol dehydrogenase expression: hsa-miR-148a-3p promotes ADH4 expression via an AGO1-dependent manner in control and ethanol-exposed hepatic cells
Jiao Luo et al.
BIOCHEMICAL PHARMACOLOGY (2021)
Improving gene function predictions using independent transcriptional components
Carlos G. Urzua-Traslavina et al.
NATURE COMMUNICATIONS (2021)
Breast cancer as an example of tumour heterogeneity and tumour cell plasticity during malignant progression
Fabiana Luond et al.
BRITISH JOURNAL OF CANCER (2021)
Metastasis is altered through multiple processes regulated by the E2F1 transcription factor
Matthew R. Swiatnicki et al.
SCIENTIFIC REPORTS (2021)
Atypical E2Fs either Counteract or Cooperate with RB during Tumorigenesis Depending on Tissue Context
Eva Moreno et al.
CANCERS (2021)
OLIG2 regulates lncRNAs and its own expression during oligodendrocyte lineage formation
Haichao Wei et al.
BMC BIOLOGY (2021)
G protein gamma 7 suppresses progression of lung adenocarcinoma by inhibiting E2F transcription factor 1
Hongyu Zheng et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2021)
被撤回的出版物: Oncogenic miR-27a delivered by exosomes binds to SFRP1 and promotes angiogenesis in renal clear cell carcinoma (Retracted article. See vol. 30, pg. 346, 2022)
Yi Hou et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2021)
Lysophosphatidic Acid Receptor Antagonists and Cancer: The Current Trends, Clinical Implications, and Trials
Yu-Hsuan Lin et al.
CELLS (2021)
Association between sleep duration and breast cancer incidence: The multiethnic cohort
Maryssa Shigesato et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
Metastatic heterogeneity of breast cancer: Molecular mechanism and potential therapeutic targets
Yiran Liang et al.
SEMINARS IN CANCER BIOLOGY (2020)
A potential target for liver cancer management, lysophosphatidic acid receptor 6 (LPAR6), is transcriptionally up-regulated by the NCOA3 coactivator
Xuan Zheng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2020)
Impact of Breast Cancer Treatment on Employment: Results of a Multicenter Prospective Cohort Study (CANTO)
Agnes Dumas et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Novel lysophosphatidic acid receptor 6 antagonists inhibit hepatocellular carcinoma growth through affecting mitochondrial function
Davide Gnocchi et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2020)
Impact of GPCR Structures on Drug Discovery
Miles Congreve et al.
CELL (2020)
The E2F family as potential biomarkers and therapeutic targets in colon cancer
Haibo Yao et al.
PEERJ (2020)
A distinctive protein signature induced by lysophosphatidic acid receptor 6 (LPAR6) expression in hepatocellular carcinoma cells
Rosa Lippolis et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)
MiR-27a-3p Targeting GSK3β Promotes Triple-Negative Breast Cancer Proliferation and Migration Through Wnt/β-Catenin Pathway
Ruizhen Wu et al.
CANCER MANAGEMENT AND RESEARCH (2020)
Endoplasmic reticulum stress-induced exosomal miR-27a-3p promotes immune escape in breast cancer via regulating PD-L1 expression in macrophages
Xiaoli Yao et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)
MicroRNA-27a-3p Reverses Adriamycin Resistance by Targeting BTG2 and Activating PI3K/Akt Pathway in Breast Cancer Cells
Bei Zhu et al.
ONCOTARGETS AND THERAPY (2020)
Lysophosphatidic Acid Receptors: Biochemical and Clinical Implications in Different Diseases
Hongjiao Xiang et al.
JOURNAL OF CANCER (2020)
Targeting the autotaxin - Lysophosphatidic acid receptor axis in cardiovascular diseases
Yang Zhao et al.
BIOCHEMICAL PHARMACOLOGY (2019)
Lysophosphatidic Acid Receptor 6 (LPAR6) Expression and Prospective Signaling Pathway Analysis in Breast Cancer
Kai Tao et al.
MOLECULAR DIAGNOSIS & THERAPY (2019)
MiR-466h-5p induces expression of myocardin with complementary promoter sequences
Ying Luo et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2019)
The Role of Non-coding RNAs in Oncology
Frank J. Slack et al.
CELL (2019)
Cell type-selective pathways and clinical associations of lysophosphatidic acid biosynthesis and signaling in the ovarian cancer microenvironment
Silke Reinartz et al.
MOLECULAR ONCOLOGY (2019)
Patterns of diverse gene functions in genomic neighborhoods predict gene function and phenotype
Matej Mihelcic et al.
SCIENTIFIC REPORTS (2019)
Effects of LPA1 and LPA6 on the regulation of colony formation activity in colon cancer cells treated with anticancer drugs
Kaede Takahashi et al.
JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION (2018)
Integrated Human Evaluation of the Lysophosphatidic Acid Pathway as a Novel Therapeutic Target in Atherosclerosis
Silvia Aldi et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2018)
SnapShot: Unconventional miRNA functions
Mihnea Paul Dragomir et al.
CELL (2018)
miRWalk: An online resource for prediction of microRNA binding sites
Carsten Sticht et al.
PLOS ONE (2018)
Preventing acute asthmatic symptoms by targeting a neuronal mechanism involving carotid body lysophosphatidic acid receptors
Nicholas G. Jendzjowsky et al.
NATURE COMMUNICATIONS (2018)
Targeting the Hippo Pathway for Breast Cancer Therapy
Liqing Wu et al.
CANCERS (2018)
UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses
Darshan S. Chandrashekar et al.
NEOPLASIA (2017)
Lysophosphatidic acid (LPA) signaling via LPA4 and LPA6 negatively regulates cell motile activities of colon cancer cells
Kaede Takahashi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
Diverse effects of LPA4, LPA5 and LPA6 on the activation of tumor progression in pancreatic cancer cells
Shuhei Ishii et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
Lysophosphatidic Acid Receptor LPAR6 Supports the Tumorigenicity of Hepatocellular Carcinoma
Antonio Mazzocca et al.
CANCER RESEARCH (2015)
Inactivation of a Gαs-PKA tumour suppressor pathway in skin stem cells initiates basal-cell carcinogenesis
Ramiro Iglesias-Bartolome et al.
NATURE CELL BIOLOGY (2015)
Predicting effective microRNA target sites in mammalian mRNAs
Vikram Agarwal et al.
ELIFE (2015)
An essential role for LPA signalling in telencephalon development
Timothy J. Geach et al.
DEVELOPMENT (2014)
The G protein α subunit Gαs is a tumor suppressor in Sonic hedgehog-driven medulloblastoma
Xuelian He et al.
NATURE MEDICINE (2014)
Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
Jianjiong Gao et al.
SCIENCE SIGNALING (2013)
bc-GenExMiner: an easy-to-use online platform for gene prognostic analyses in breast cancer
Pascal Jezequel et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters
Guangchuang Yu et al.
OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY (2012)
G protein-coupled receptor P2Y5 and its ligand LPA are involved in maintenance of human hair growth
Sandra M. Pasternack et al.
NATURE GENETICS (2008)